However, the mortality rate remains relatively low compared to other cancer types [ 1 ], and it has shown a decreasing trend in recent years due to advancements in diagnosis and treatment.
← all excerpts
177Lu-PSMA radioligand therapy for isolated bilateral adrenal metastases from prostate cancer.
1
—
—